Roche

Hemophilia A Market Forecast and Assessment
Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape

Hemophilia A treatment scenario before the launch of HEMLIBRA Despite the ups and downs throughout history, the management of hemophilia A patients substantially improved over the past 40 years...


clinical-diagnostics-market-outlook
Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market

Clinical Diagnosis (Dx) is the identification and confirmation of disease or disorder or exposure to xenobiotics to explain the clinical manifestations shown by the patient. It is also performed t...


retinal-vein-occlusion-market-assessment
A Market Space Beyond Lucentis and Eylea for Retinal Vein Occlusion Treatment

Competitive inroads by Regeneron’s Eylea in the retinal vein occlusion treatment landscape changed the market once dominated by Roche.Moving forward, RVO’s robust pipeline, along with several VEGF...


pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google
Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic bui...

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...


top-pharma-biotech-companies-by-revenue-share-drugs-therapies-2020-2021-worldwide
Top 7 Pharma Industry Leaders in 2020 By the Numbers

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...


Angelman syndrome
Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market. The Angelman Syndrome c...


recent-pharma-happenings-for-asher-bio-roche-novartis-epimab
Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand ...

Asher Bio raises USD 55 Million in Series A financing Asher Biotherapeutics, a biotechnology company developing exactly targeted immunotherapies for cancer and other diseases, raised USD 55 Mil...


Head and Neck Cancers Market
Navigating Through the Treatment Market Landscape of Head and Neck Cancers

Head and neck cancer account for about 4% of all cancers in the United States. According to GloboCan, the HNSCC incidence in the US in 2020 was estimated to be 63,520 cases. As per estimates, it w...


Angelman Syndrome Market Landscape and Late-stage Clinical Failures
Angelman Syndrome Market: Insights Into The Recent Late-Stage Drug Failures And Novel Approaches ...

Angelman syndrome (AS) is a complex genetic rare disorder that affects the nervous system. The first sign of a child suffering from Angelman syndrome is a delay in development, such as the inabili...


recent-pharma-biotech-healthcare-news-and-updates-for-nih-roche-regeneron-gsk
NIH awards $107M for COVID-19 testing tech; GSK secures rights; Roche’s bispecific matches ...

NIH awards USD 107 Million for radical COVID-19 testing tech  The National Institutes of Health (NIH) awarded over USD 107 million for radical approaches to testing for COVID-19 and tracin...